Cargando…

Modelling the Human Blood–Brain Barrier in Huntington Disease

While blood–brain barrier (BBB) dysfunction has been described in neurological disorders, including Huntington’s disease (HD), it is not known if endothelial cells themselves are functionally compromised when promoting BBB dysfunction. Furthermore, the underlying mechanisms of BBB dysfunction remain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vignone, Domenico, Gonzalez Paz, Odalys, Fini, Ivan, Cellucci, Antonella, Auciello, Giulio, Battista, Maria Rosaria, Gloaguen, Isabelle, Fortuni, Silvia, Cariulo, Cristina, Khetarpal, Vinod, Dominguez, Celia, Muñoz-Sanjuán, Ignacio, Di Marco, Annalise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321930/ https://www.ncbi.nlm.nih.gov/pubmed/35887162 http://dx.doi.org/10.3390/ijms23147813

Ejemplares similares

Establishment of an in Vitro Human Blood-Brain Barrier Model Derived from Induced Pluripotent Stem Cells and Comparison to a Porcine Cell-Based System
por: Di Marco, Annalise, et al.
Publicado: (2020)

Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington’s disease
por: Bertoglio, Daniele, et al.
Publicado: (2021)

Efficacy of PEGylated ciliary neurotrophic factor superagonist variant in diet-induced obesity mice
por: Battista, Maria Rosaria, et al.
Publicado: (2022)

In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using (11)C-CHDI-180R PET in a Nonhuman Primate Model of Huntington Disease
por: Bertoglio, Daniele, et al.
Publicado: (2023)

Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem
por: Bertoglio, Daniele, et al.
Publicado: (2022)

Elevated Type 1 Metabotropic Glutamate Receptor Availability in a Mouse Model of Huntington’s Disease: a Longitudinal PET Study
por: Bertoglio, Daniele, et al.
Publicado: (2020)

Quantifying autophagy using novel LC3B and p62 TR-FRET assays
por: Bresciani, Alberto, et al.
Publicado: (2018)

Benefits of global mutant huntingtin lowering diminish over time in a Huntington’s disease mouse model
por: Marchionini, Deanna M., et al.
Publicado: (2022)

Rapid and robust patterns of spontaneous locomotor deficits in mouse models of Huntington’s disease
por: Heikkinen, Taneli, et al.
Publicado: (2020)

A Monoclonal Antibody TrkB Receptor Agonist as a Potential Therapeutic for Huntington’s Disease
por: Todd, Daniel, et al.
Publicado: (2014)

The PDE1/5 Inhibitor SCH-51866 Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington’s Disease
por: Beaumont, Vahri, et al.
Publicado: (2014)

Global Rhes knockout in the Q175 Huntington’s disease mouse model
por: Heikkinen, Taneli, et al.
Publicado: (2021)

Enfermedad de Huntington
por: Muñoz García, Esteban
Publicado: (1996)

IKBKB reduces huntingtin aggregation by phosphorylating serine 13 via a non-canonical IKK pathway
por: Cariulo, Cristina, et al.
Publicado: (2023)

Phosphorylation of huntingtin at residue T3 is decreased in Huntington’s disease and modulates mutant huntingtin protein conformation
por: Cariulo, Cristina, et al.
Publicado: (2017)

Polyglutamine expansion affects huntingtin conformation in multiple Huntington’s disease models
por: Daldin, Manuel, et al.
Publicado: (2017)

Longitudinal investigation of changes in resting-state co-activation patterns and their predictive ability in the zQ175 DN mouse model of Huntington’s disease
por: Adhikari, Mohit H., et al.
Publicado: (2023)

Huntington's Disease: An Immune Perspective
por: Nayak, Annapurna, et al.
Publicado: (2011)

Human glia can both induce and rescue aspects of disease phenotype in Huntington disease
por: Benraiss, Abdellatif, et al.
Publicado: (2016)

Pharmacokinetics of memantine in rats and mice
por: Beconi, Maria G., et al.
Publicado: (2012)

Striatal infusion of cholesterol promotes dose‐dependent behavioral benefits and exerts disease‐modifying effects in Huntington's disease mice
por: Birolini, Giulia, et al.
Publicado: (2020)

Characterization of HTT Inclusion Size, Location, and Timing in the zQ175 Mouse Model of Huntington´s Disease: An In Vivo High-Content Imaging Study
por: Carty, Nikisha, et al.
Publicado: (2015)

Role of the Gut–Liver Axis in the Pathobiology of Cholangiopathies: Basic and Clinical Evidence
por: Bragazzi, Maria Consiglia, et al.
Publicado: (2023)

Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington’s disease mice
por: Bondulich, Marie K., et al.
Publicado: (2017)

Efficacy of Selective PDE4D Negative Allosteric Modulators in the Object Retrieval Task in Female Cynomolgus Monkeys (Macaca fascicularis)
por: Sutcliffe, Jane S., et al.
Publicado: (2014)

Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation
por: Capsoni, Simona, et al.
Publicado: (2013)

Kinetic Modelling and Test–Retest Reproducibility for the Dopamine D(1)R Radioligand [(11)C]SCH23390 in Healthy and Diseased Mice
por: Bertoglio, Daniele, et al.
Publicado: (2020)

Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington's Disease
por: Heikkinen, Taneli, et al.
Publicado: (2012)

Platelet abnormalities in Huntington’s disease
por: Denis, Hélèna L, et al.
Publicado: (2019)

Rethinking logic: logic in relation to mathematics, evolution, and method
por: Cellucci, Carlo
Publicado: (2014)

Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY
por: Orth, Michael, et al.
Publicado: (2011)

Emerging Therapies for Advanced Cholangiocarcinoma: An Updated Literature Review
por: Vignone, Anthony, et al.
Publicado: (2021)

Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery
por: Borbély, Adina, et al.
Publicado: (2019)

Archer Milton Huntington
por: Gilman Proske, Beatrice, 1899-
Publicado: (1963)

Neuropsychiatry of Huntington's disease
por: Rosenblatt, Adam
Publicado: (2007)

Huntington Disease in Asia
por: Xu, Miao, et al.
Publicado: (2015)

The History of Huntington's Chorea
por: Stevens, David L.
Publicado: (1972)

Irritability in Huntington’s Disease
por: Karagas, Nicholas E., et al.
Publicado: (2020)

Huntington’s and the History of Sleep
por: Wexler, Alice R.
Publicado: (2023)

White matter cortico-striatal tracts predict apathy subtypes in Huntington's disease
por: De Paepe, Audrey E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lsd029lhrpp2tfk2e7qmcghurr